Keyphrases
Health-related Quality of Life
100%
Chronic Inflammatory Neuropathies
100%
Health-related Quality of Life Measures
66%
Treatment Interventions
33%
Inflammatory Neuropathy
33%
Route of Administration
16%
Patient Well-being
16%
Immunoglobulin
16%
Quality of Life
16%
Self-report Measures
16%
Heterogeneous Groups
16%
Drug Administration
16%
Disease-specific Quality of Life
16%
Patient Demographics
16%
Normative Values
16%
Absence of Evidence
16%
Corticosteroids
16%
Patient Benefit
16%
Treatment Trials
16%
Functional Quality
16%
Functional Status
16%
Patient Assessment
16%
Anti-MAG Neuropathy
16%
Disease Intervention
16%
Rituximab
16%
Generic Health-related Quality of Life
16%
Functional Scale
16%
Chronic Inflammatory Demyelinating Polyneuropathy
16%
Intravenous Immunoglobulin (IVIg)
16%
Physical Domain
16%
Immunology and Microbiology
Intravenous Immunoglobulin
100%
Functional Status
100%
Chronic Inflammatory Demyelinating Polyneuropathy
100%
Rituximab
100%
Pharmacology, Toxicology and Pharmaceutical Science
Neuropathy
100%
Disease
37%
Drug Administration
12%
Functional Status
12%
Rituximab
12%
Chronic Inflammatory Demyelinating Polyneuropathy
12%
Neuroscience
Neuropathy
100%
Intravenous Immunoglobulin
12%
Polyneuropathy
12%
Rituximab
12%